Senti Biosciences is trading at $0.24, up +10.37%, during the October 29, 2026 session; no clear company-specific catalyst was identified.
- The stock recorded a second consecutive daily gain, following a 15.21% rise on October 28.
- Recent coverage discussed a director resignation and an October 30 record date for contingent value rights, but did not establish either as the cause of the move.
- Broader U.S. indexes were lower, offering no explanation for the stock’s rise.